| CITEX | RTEHX | CITEX / RTEHX | |
| Total Expense Ratio | 0.93 | 1.12 | 83% |
| Annual Report Gross Expense Ratio | 0.93 | 1.12 | 83% |
| Fund Existence | 24 years | 11 years | - |
| Gain YTD | 6.320 | 6.139 | 103% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 26.2B | 26.2B | 100% |
| Annual Yield % from dividends | 6.08 | 5.88 | 103% |
| Returns for 1 year | 6.66 | 6.45 | 103% |
| Returns for 3 years | 31.03 | 30.26 | 103% |
| Returns for 5 years | 32.63 | 31.31 | 104% |
| Returns for 10 years | 77.82 | 73.69 | 106% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XVOL | 23.65 | N/A | N/A |
| Acruence Active Hedge US Equity ETF | |||
| LCDS | 63.76 | N/A | N/A |
| JPMorgan Fundamental Data Sci Lg Cor ETF | |||
| PJP | 101.57 | -0.71 | -0.69% |
| Invesco Pharmaceuticals ETF | |||
| DSL | 11.49 | -0.10 | -0.86% |
| DOUBLELINE Income SOLUTIONS FUND | |||
| LEAD | 74.62 | -2.20 | -2.86% |
| Siren DIVCON Leaders Dividend ETF | |||